Clinical trial
A Study of Persons With Gout Who Do Not Respond to or Are Allergic to…
NCT00080210 · Savient Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00080210 |
|---|---|
| Title | A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy |
| Official title | A Phase II Study of Multiple Doses of Intravenous Puricase in Subjects With Hyperuricemia and Refractory Gout |
| Lead sponsor | Savient Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gout |
| Intervention type | Drug |
| Interventions | Puricase |
| Enrollment | 40 |
| Start date | Mar 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Mar 25, 2004 |
| Last update posted | Jun 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: